JPWO2021167032A1 - - Google Patents

Info

Publication number
JPWO2021167032A1
JPWO2021167032A1 JP2022501993A JP2022501993A JPWO2021167032A1 JP WO2021167032 A1 JPWO2021167032 A1 JP WO2021167032A1 JP 2022501993 A JP2022501993 A JP 2022501993A JP 2022501993 A JP2022501993 A JP 2022501993A JP WO2021167032 A1 JPWO2021167032 A1 JP WO2021167032A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022501993A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021167032A1 publication Critical patent/JPWO2021167032A1/ja
Priority to JP2026000081A priority Critical patent/JP2026040780A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP2022501993A 2020-02-18 2021-02-18 Pending JPWO2021167032A1 (https=)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026000081A JP2026040780A (ja) 2020-02-18 2026-01-05 腸炎および／または肝炎を治療および／または予防するための薬剤および食品

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020024984 2020-02-18
PCT/JP2021/006227 WO2021167032A1 (ja) 2020-02-18 2021-02-18 腸炎および／または肝炎を治療および／または予防するための薬剤および食品

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026000081A Division JP2026040780A (ja) 2020-02-18 2026-01-05 腸炎および／または肝炎を治療および／または予防するための薬剤および食品

Publications (1)

Publication Number Publication Date
JPWO2021167032A1 true JPWO2021167032A1 (https=) 2021-08-26

Family

ID=77392262

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022501993A Pending JPWO2021167032A1 (https=) 2020-02-18 2021-02-18
JP2026000081A Pending JP2026040780A (ja) 2020-02-18 2026-01-05 腸炎および／または肝炎を治療および／または予防するための薬剤および食品

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026000081A Pending JP2026040780A (ja) 2020-02-18 2026-01-05 腸炎および／または肝炎を治療および／または予防するための薬剤および食品

Country Status (3)

Country Link
US (1) US20230063703A1 (https=)
JP (2) JPWO2021167032A1 (https=)
WO (1) WO2021167032A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2022080249A1 (https=) * 2020-10-12 2022-04-21
JPWO2023002939A1 (https=) * 2021-07-19 2023-01-26
JP2024051242A (ja) * 2022-09-30 2024-04-11 学校法人早稲田大学 オートファジー亢進剤
CN116531359B (zh) * 2023-05-12 2025-02-14 同济大学 β-丙氨酸在制备缓解结肠炎症状药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6767890B1 (en) * 1998-11-18 2004-07-27 Coastside Bio Resources Peptides having anti-cancer and anti-inflammatory activity
DK3061766T3 (da) * 2009-04-28 2020-03-16 Univ Vanderbilt Sammensætninger og fremgangsmåder til behandlingen af sygdomme der involverer epitelcelleapoptose

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
SASABE J., ET AL.: "Interplay between microbial D-amino acids and host D-amino acid oxidase modifies murine mucosal defe", NAT MICROBIOL., vol. 1(10), JPN6021016347, 2016, pages 16125, ISSN: 0005540463 *
岡田 かおり ほか: "黒酢及び米酢中のD-及びL-アミノ酸の定量的解析", 微量栄養素研究, vol. 29, JPN6021016344, 2012, pages 62 - 66, ISSN: 0005540461 *
金井 隆典: "ヒト疾患糞便移植マウスモデルを用いた炎症性腸疾患ディスバイオ−シスの解明", 科学研究費助成事業 研究成果報告書, JPN6021016345, 2018, ISSN: 0005540462 *
静間 徹 ほか: "黒酢によるデキストラン硫酸ナトリウム誘発性大腸炎の軽減効果", 外科と代謝・栄養, vol. 47, no. 1, JPN6021016343, 2013, pages 1 - 7, ISSN: 0005540460 *

Also Published As

Publication number Publication date
US20230063703A1 (en) 2023-03-02
WO2021167032A1 (ja) 2021-08-26
JP2026040780A (ja) 2026-03-09

Similar Documents

Publication Publication Date Title
JPWO2023002939A1 (https=)
JPWO2022080249A1 (https=)
CN305717300S (https=)
CN305723923S (https=)
CN305537382S (https=)
CN305535669S (https=)
CN305535406S (https=)
CN305534699S (https=)
CN305534547S (https=)
CN305678716S (https=)
CN305534070S (https=)
CN305533199S (https=)
CN305532386S (https=)
CN305531129S (https=)
CN305530727S (https=)
CN305530041S (https=)
CN305678713S (https=)
CN305706325S (https=)
CN305699734S (https=)
CN305529147S (https=)
CN305528606S (https=)
CN305697223S (https=)
CN305528475S (https=)
CN305697109S (https=)
CN305528194S (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220715

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240215

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20241224

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250304

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250502

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250630

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250930

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260105